Pimecrolimus 1 percent cream and pulsed dye laser in treatment of a patient with reticular erythematous mucinosis syndrome.

Abstract

We report on the efficacy of twice daily application of pimecrolimus 1 percent cream in a 48-year-old woman with reticular erythematous mucinosis (REM) syndrome and compare its results with pulsed dye laser (PDL) on the other side of her chest and back. The patient was previously treated by hydroxychloroquine but only a fair response was observed. After application of 5 months of pimecrolimus, the lesions completely resolved and the result was comparable with the other side of her body treated by pulsed dye laser PDL. Topical pimecrolimus and pulsed dye laser appear to be effective and safe treatments for REM.

• Authors: Parvin Mansouri, Susan Farshi, Arezo Nahavandi, Zahra Safaie-Naraghi
• Journal: Dermatology online journal (Dermatol Online J) Vol. 13 Issue 2 Pg. 22 (May 01 2007) ISSN: 1087-2108 [Electronic] United States
• PMID: 17498441 (Publication Type: Case Reports, Journal Article)

Chemical References

• pimecrolimus
• Tacrolimus

Topics

• Administration, Topical
• Biopsy, Needle
• Combined Modality Therapy
• Erythema (pathology, therapy)
• Female
• Follow-Up Studies
• Humans
• Immunohistochemistry
• Low-Level Light Therapy (methods)
• Middle Aged
• Mucinoses (pathology, therapy)
• Syndrome
• Tacrolimus (analogs & derivatives, therapeutic use)
• Treatment Outcome